Earl's vaccine mixes glycerin with the outer membrane protein complex (cpme), den. Meningidis, to create a very small protein poisoning (VSP) for subcutaneous management. Adyuvantes is no longer needed for these compositions. These components provide lymphoid immunotherapy, especially n-acgm3 / VSP and n-gggm3 / VSP. The advantage of these components is that they are less acidic at the injection site, can be used more easily, and have less impact on patients.
展开▼
